Triple
T4229705
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | National Cancer Advisory Board |
E94548
|
entity |
| Predicate | legalBasis |
P125
|
FINISHED |
| Object | National Cancer Act of 1971 |
E15520
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: National Cancer Act of 1971 | Statement: [National Cancer Advisory Board, legalBasis, National Cancer Act of 1971]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: National Cancer Act of 1971 Context triple: [National Cancer Advisory Board, legalBasis, National Cancer Act of 1971]
-
A.
National Cancer Act of 1971
chosen
The National Cancer Act of 1971 is a landmark U.S. law that greatly expanded federal funding and coordination for cancer research, prevention, and treatment, helping launch the modern "war on cancer."
-
B.
National Cancer Institute Act of 1937
The National Cancer Institute Act of 1937 is a U.S. federal law that formally established the National Cancer Institute as the government’s principal agency for cancer research and control.
-
C.
Kefauver–Harris Drug Amendments of 1962
The Kefauver–Harris Drug Amendments of 1962 are U.S. federal regulations that strengthened drug safety and efficacy requirements, mandating proof of effectiveness and stricter oversight of pharmaceutical marketing and manufacturing.
-
D.
Orphan Drug Act of 1983
The Orphan Drug Act of 1983 is a U.S. law that incentivizes the development of treatments for rare diseases by offering benefits such as market exclusivity, tax credits, and research grants to drug manufacturers.
-
E.
1969 Public Health Cigarette Smoking Act
The 1969 Public Health Cigarette Smoking Act was a U.S. federal law that significantly strengthened cigarette labeling requirements and banned cigarette advertising on television and radio to reduce smoking-related health risks.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69b3453700a08190ae88792e3dc63207 |
completed | March 12, 2026, 10:59 p.m. |
| NER | Named-entity recognition | batch_69b34e61ccc081909b880baf1d6a0f24 |
completed | March 12, 2026, 11:38 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b5964cd0088190a97ca5278046ba7b |
completed | March 14, 2026, 5:09 p.m. |
Created at: March 12, 2026, 11:05 p.m.